# Werfen opens new building at Hemostasis and Acute Care Diagnostics Technology Center in Bedford, MA

Werfen opened a new building at its Hemostasis and Acute Care Diagnostics Technology Center in Bedford, Massachusetts, adding 105,000 square feet with an investment of over $50 million. The expansion increases capacity for research, development and manufacturing of specialized diagnostics.

- Type: Expansion
- Announced: 2024-12-03
- Where: Bedford, Massachusetts, United States
- Value: $50.0M
- Starts operating: 3 Dec 2024
- Status: completed
- Capacity: 105,000 square feet
- Products: specialized diagnostic instruments, reagents, automation workcells, data management systems for hemostasis and acute care
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Werfen](https://endata.com/companies/21583.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/werfen-expands-hemostasis-and-acute-care-diagnostics-technology-center-in-bedford-ma-302320246.html), 2024-12-03: "Werfen today announced the opening of a new building, expanding its capabilities for innovation in Specialized Diagnostics, at its Hemostasis and Acute Care Diagnostics Technology Center, in Bedford, MA, USA."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.